Invention Application
- Patent Title: SELECTIVE 'beta'3 ADRENERGIC AGONISTS
- Patent Title (中): 选择性beta 3 ADRENERGIC AGONISTS
-
Application No.: PCT/US1996015135Application Date: 1996-09-20
-
Publication No.: WO1997010825A1Publication Date: 1997-03-27
- Inventor: ELI LILLY AND COMPANY
- Applicant: ELI LILLY AND COMPANY , BELL, Michael, G. , CROWELL, Thomas, A. , DROSTE, Christine, A. , JESUDASON, Cynthia, D. , MATTHEWS, Donald, P. , MCDONALD, John, H., III , NEEL, David, A. , RITO, Christopher, J. , SHUKER, Anthony, J. , WINTER, Mark, A.
- Assignee: ELI LILLY AND COMPANY,BELL, Michael, G.,CROWELL, Thomas, A.,DROSTE, Christine, A.,JESUDASON, Cynthia, D.,MATTHEWS, Donald, P.,MCDONALD, John, H., III,NEEL, David, A.,RITO, Christopher, J.,SHUKER, Anthony, J.,WINTER, Mark, A.
- Current Assignee: ELI LILLY AND COMPANY,BELL, Michael, G.,CROWELL, Thomas, A.,DROSTE, Christine, A.,JESUDASON, Cynthia, D.,MATTHEWS, Donald, P.,MCDONALD, John, H., III,NEEL, David, A.,RITO, Christopher, J.,SHUKER, Anthony, J.,WINTER, Mark, A.
- Priority: US60/004,082 19950921
- Main IPC: A61K31/44
- IPC: A61K31/44
Abstract:
The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective beta 3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating Type II diabetes, comprising administering to a mammal in need thereof compounds of Formulas (I) and (II).
Information query
